Collects samples and data from adults with ANCA-associated vasculitis over time
Collects blood, urine, stool and questionnaire data from adults with ANCA-associated vasculitis.
Plain-language title generated from the registry record
Registry title: Biocollection of Patients With ANCA Associated Vasculitis
Key facts
- Where
- Brest, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Source: NCT05364892, who can take part
Where in France
- CHRU de Brest - Service de rhumatologieBrest, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Brest
- Trial code
- NCT05364892
- Record updated
- 25 June 2026
- Original description
As rare disease, vasculitis affects a small number of patients, the cohorts available in the literature are few and the pathophysiological mechanisms remain to be elucidated. The collection of standardized data within a patientheque as part of a multi-year follow-up will facilitate the study of the characteristics of these diseases. This may, in particular, address the main objective of identifying predictors of relapse, as well as secondary objectives for predictive factors of mortality, infectious, cardiovascular or neoplastic complications that affect the prognosis of vasculitis in order to establish a more appropriate management of the patients concerned.Read full original descriptionShow less
Biocollection of Patients With ANCA Associated Vasculitis Diagnosed Within the CERAINO Autoimmune Disease Reference Center, Part of the Global BRAISE Project (B-dependent Rare AutoImmune DiseaSES
As rare disease, vasculitis affects a small number of patients, the cohorts available in the literature are few and the pathophysiological mechanisms remain to be elucidated. The collection of standardized data within a patientheque as part of a multi-year follow-up will facilitate the study of the characteristics of these diseases. This may, in particular, address the main objective of identifying predictors of relapse, as well as secondary objectives for predictive factors of mortality, infectious, cardiovascular or neoplastic complications that affect the prognosis of vasculitis in order to establish a more appropriate management of the patients concerned.
Inclusion: Major patients with no upper age limit; Patients assessed as part of the reference centre for rare autoimmune diseases at the CHRU in Brest; Patients for whom a diagnosis of ANCA-associated vasculitis is made by the physician in charge of the patient, according to the definitions of the Chapel-Hill Consensus Conference; Patient affiliated with Social Security; Patient who has signed written informed consent.
Exclusion: Hemoglobin (Hb) < 7g/dL; Minor; Patients unable to consent; Patients refusing to participate in research; Patient under legal protection (tutelage, curatorship); Pregnant or lactating women.